Predicting IVF outcome in poor ovarian responders

[1] Macklon NS(2006)The science behind 25 years of ovarian stimulation for in vitro fertilization Endocr Rev 27 170-207

[2] Stouffer RL(2011)Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum Reprod 26 1768-1774

[3] Giudice LC(2011)ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum Reprod 26 1616-1624

[4] Fauser BC(1997)Assisted conception following poor ovarian response to gonadotrophin stimulation Br J Obstet Gynaecol 104 521-527

[5] Sunkara SK(2014)Management of poor responders in IVF: is there anything new? Biomed Res Int 2014 357-373

[6] Rittenberg V(2000)Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet J Assist Reprod Genet 17 331-335

[7] Raine-Fenning N(2005)Agonist, "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment Fertil Steril 83 357-361

[8] Bhattacharya S(2020)Stop GnRH-agonist combined with multiple-dose GnRH-antagonist for patients with elevated peak serum progesterone levels undergoing ovarian stimulation for IVF: a proof of concept Gynecol Obstet Invest 85 277-286

[9] Zamora J(1994)The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program Gynecol Endocrinol 8 60-437

[10] Coomarasamy A(2015)Triggering final follicular maturation–hCG, GnRH-agonist or both, when and to whom? J Ovarian Res 8 431-2413

[1] Macklon NS(2006)The science behind 25 years of ovarian stimulation for in vitro fertilization Endocr Rev 27 170-207

[2] Stouffer RL(2011)Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum Reprod 26 1768-1774

[3] Giudice LC(2011)ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum Reprod 26 1616-1624

[4] Fauser BC(1997)Assisted conception following poor ovarian response to gonadotrophin stimulation Br J Obstet Gynaecol 104 521-527

[5] Sunkara SK(2014)Management of poor responders in IVF: is there anything new? Biomed Res Int 2014 357-373

[6] Rittenberg V(2000)Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet J Assist Reprod Genet 17 331-335

[7] Raine-Fenning N(2005)Agonist, "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment Fertil Steril 83 357-361

[8] Bhattacharya S(2020)Stop GnRH-agonist combined with multiple-dose GnRH-antagonist for patients with elevated peak serum progesterone levels undergoing ovarian stimulation for IVF: a proof of concept Gynecol Obstet Invest 85 277-286

[9] Zamora J(1994)The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program Gynecol Endocrinol 8 60-437

[10] Coomarasamy A(2015)Triggering final follicular maturation–hCG, GnRH-agonist or both, when and to whom? J Ovarian Res 8 431-2413